Sargaco, Beatriz; Oliveira, Patricia Almeida; Antunes, Maria Luz; Moreira, Ana Catarina published the artcile< Effects of the Ketogenic Diet in the Treatment of Gliomas: A Systematic Review>, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is ketogenic diet glioma treatment; glioblastoma; glioma; ketogenic diet; survival.
The ketogenic diet (KD) is a restrictive therapeutic diet, distinguished by being hyperlipidic, normoproteic, and hypoglucidic. This diet simulates biochem. changes related to fasting periods to achieve systemic ketosis. The metabolic particularities of glioma tumors motivated the rise in investigations and nutritional strategies, such as KD, to modulate the glycemic response as a treatment. This systematic review followed the PRISMA recommendations and was published in PROSPERO, with the identification CRD42021264173. The databases used were EMBASE, PubMed/Medline, Scopus, and Web of Science, and the studies were analyzed using the web-based application Rayyan. To analyze the risk of bias, Cochrane RevMan 5 software was used. For the anal. and treatment of statistical data, Microsoft Excel was used. A total of nine original articles were included. Data on survival, symptomol., and quality of life were collected. Mean overall survival was 15.9 mo. Constipation and fatigue were the most reported symptoms. In 44.4% of the studies, an improvement in the quality of life was found. The KD is supported by most published studies as an effective therapy in the treatment of malignant gliomas due to its pos. effects on patient survival. It was not possible to conclude the effectiveness of KD on quality of life.
Nutrients published new progress about Anaplastic astrocytoma. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics